Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region

Danique Berger, Nynke van den Berg, Vincent van der Noort, Bernies van der Hiel, Renato A. Valdés Olmos, Tessa A. Buckle, Gijs KleinJan, Oscar Roberto Brouwer, Lenka Vermeeren, Baris Karakullukçu, Michiel van den Brekel, Bart van der Wiel, Omgo E Nieweg, Alfons Balm, Fijs E van Leeuwen and Martin Klop
Journal of Nuclear Medicine February 2021, jnumed.120.246819; DOI: https://doi.org/10.2967/jnumed.120.246819
Danique Berger
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nynke van den Berg
2 Stanford University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent van der Noort
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernies van der Hiel
3 Netherlands Cancer Institute;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renato A. Valdés Olmos
3 Netherlands Cancer Institute;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tessa A. Buckle
4 Leiden University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gijs KleinJan
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oscar Roberto Brouwer
3 Netherlands Cancer Institute;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lenka Vermeeren
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baris Karakullukçu
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiel van den Brekel
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart van der Wiel
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omgo E Nieweg
5 Melanoma Institute Australia //and// University of Sydney.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfons Balm
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fijs E van Leeuwen
6 LUMC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Klop
1 Antoni van Leeuwenhoek, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Sentinel lymph node (SN) biopsy (SLNB) has proven to be a valuable tool for staging melanoma patients. Since its introduction in the early 1990s, this procedure has undergone several technological refinements, including the introduction of single photon emission computed tomography combined with computed tomography (SPECT/CT) as well as radio- and fluorescence-guidance. The purpose of the current study was to evaluate the effect of this technological evolution on SLNB in the head and neck region. Primary endpoint was the false-negative (FN) rate. Secondary endpoints were number of harvested SNs, overall operation time, operation time per harvested SN and postoperative complications. Patients and Methods: A retrospective database was queried for cutaneous head and neck melanoma patients who underwent SLNB at The Netherlands Cancer Institute between 1993 and 2016. The implementation of new detection techniques was divided in 4 groups: (1) 1993-2005, with preoperative lymphoscintigraphy and intraoperative use of both a gamma ray detection probe and patent blue (n = 30); (2) 2006-2007, with addition of preoperative roadmaps based on SPECT/CT (n = 15); (3) 2008-2009, with intraoperative use of a portable gamma camera (n = 40); and (4) 2010-2016, with the addition of near-infrared fluorescence guidance (n = 192). Results: A total of 277 patients were included. At least one SN was identified in all patients. A tumor-positive SN was found in 59 patients (21.3%), 10 in group 1 (33.3%), 3 in group 2 (20.0%), 6 in group 3 (15.0%) and 40 in group 4 (20.8%). Regional recurrences of patients with tumor-negative SNs resulted in an overall FN rate of 11.9% (FN groups 1: 16.7%; 2: 0%; 3: 14.3%; 4: 11.1%). The number of harvested nodes increased with advancing technologies (P = 0.003) whereas Breslow thickness and operation time per harvested SN decreased (P = 0.003 and P = 0.017, respectively). There was no significant difference in percentage of tumor-positive SNs, overall operation time and complication rate between the different groups. Conclusion: The use of advanced detection technologies led to a higher number of identified SNs without increase in overall operation time, which may indicate an improved surgical efficiency. Operation time per harvested SN decreased, the average FN rate remained 11.9% and unchanged over 23 years. There was no significant change in postoperative complication rate.

  • Oncology: Head and neck
  • Oncology: Melanoma
  • Radiopharmaceuticals
  • Melanoma
  • false negative
  • head and neck
  • sentinel lymph node biopsy
  • Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (5)
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
Danique Berger, Nynke van den Berg, Vincent van der Noort, Bernies van der Hiel, Renato A. Valdés Olmos, Tessa A. Buckle, Gijs KleinJan, Oscar Roberto Brouwer, Lenka Vermeeren, Baris Karakullukçu, Michiel van den Brekel, Bart van der Wiel, Omgo E Nieweg, Alfons Balm, Fijs E van Leeuwen, Martin Klop
Journal of Nuclear Medicine Feb 2021, jnumed.120.246819; DOI: 10.2967/jnumed.120.246819

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
Danique Berger, Nynke van den Berg, Vincent van der Noort, Bernies van der Hiel, Renato A. Valdés Olmos, Tessa A. Buckle, Gijs KleinJan, Oscar Roberto Brouwer, Lenka Vermeeren, Baris Karakullukçu, Michiel van den Brekel, Bart van der Wiel, Omgo E Nieweg, Alfons Balm, Fijs E van Leeuwen, Martin Klop
Journal of Nuclear Medicine Feb 2021, jnumed.120.246819; DOI: 10.2967/jnumed.120.246819
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions
  • First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
  • Safety and efficacy of holmium-166 radioembolization in hepatocellular carcinoma – the HEPAR Primary study
Show more Clinical Investigations (Human)

Clinical (Oncology: Head and Neck)

  • 18F FDG PET/CT Staging of Head and Neck Cancer: Inter-observer agreement and accuracy – Results from multicenter ACRIN 6685 Clinical Trial
  • Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma
  • FDG-PET/CT-based prognostic survival model after surgery for head and neck cancer
Show more Clinical (Oncology: Head and Neck)

Similar Articles

Keywords

  • Oncology: Head and neck
  • Oncology: Melanoma
  • Radiopharmaceuticals
  • melanoma
  • false negative
  • head and neck
  • sentinel lymph node biopsy
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire